Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (760) 760
science & technology (639) 639
life sciences & biomedicine (622) 622
heptavalent pneumococcal conjugate vaccine (610) 610
infant (544) 544
pneumococcal vaccines - administration & dosage (538) 538
child, preschool (453) 453
female (423) 423
male (420) 420
pneumococcal infections - prevention & control (399) 399
immunology (397) 397
vaccines (385) 385
infectious diseases (370) 370
pneumococcal vaccines - immunology (365) 365
child (313) 313
biological and medical sciences (310) 310
pneumococcal infections - epidemiology (292) 292
vaccination (265) 265
microbiology (257) 257
pneumonia (241) 241
streptococcus pneumoniae (233) 233
medical sciences (225) 225
immunization (221) 221
streptococcus pneumoniae - classification (210) 210
pediatrics (207) 207
adolescent (206) 206
streptococcus pneumoniae - immunology (198) 198
streptococcus pneumoniae - isolation & purification (198) 198
serotyping (190) 190
medicine, research & experimental (183) 183
research & experimental medicine (183) 183
pneumococcal infections - microbiology (182) 182
children (179) 179
bacterial diseases (177) 177
human bacterial diseases (172) 172
adult (170) 170
allergy and immunology (168) 168
streptococcus infections (163) 163
staphylococcal infections, streptococcal infections, pneumococcal infections (161) 161
pneumococcal conjugate vaccine (160) 160
incidence (159) 159
vaccines, conjugate - administration & dosage (153) 153
infant, newborn (151) 151
fundamental and applied biological sciences. psychology (145) 145
meningococcal vaccines - administration & dosage (144) 144
antibodies, bacterial - blood (139) 139
middle aged (138) 138
aged (135) 135
vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (135) 135
bacteriology (133) 133
pneumococcal vaccine (132) 132
pneumococcal infections - immunology (131) 131
applied microbiology (129) 129
miscellaneous (126) 126
immunization schedule (124) 124
age (123) 123
heptavalent pneumococcal conjugate vaccine - administration & dosage (119) 119
bacterial pneumonia (106) 106
pneumococcal vaccines - adverse effects (102) 102
vaccines, conjugate - immunology (102) 102
nasopharynx - microbiology (101) 101
young adult (97) 97
epidemiology (94) 94
meningitis (94) 94
research (91) 91
abridged index medicus (88) 88
streptococcus pneumoniae - drug effects (84) 84
conjugate vaccines (82) 82
meningococcal vaccines - immunology (80) 80
aged, 80 and over (77) 77
dosage and administration (76) 76
heptavalent pneumococcal conjugate vaccine - immunology (75) 75
invasive pneumococcal disease (75) 75
carrier state - microbiology (73) 73
children & youth (73) 73
pneumococcal infections (73) 73
studies (73) 73
infants (72) 72
analysis (69) 69
risk factors (68) 68
immunoglobulin g - blood (67) 67
prevalence (67) 67
serogroup (67) 67
serotypes (67) 67
ear diseases (65) 65
prevention (65) 65
mortality (64) 64
prospective studies (63) 63
health aspects (62) 62
pneumonia, pneumococcal - prevention & control (62) 62
microbial sensitivity tests (61) 61
carrier state - epidemiology (60) 60
pneumococcal vaccines (60) 60
drug resistance, bacterial (59) 59
anti-bacterial agents - pharmacology (58) 58
immunogenicity (55) 55
immunization programs (52) 52
retrospective studies (52) 52
united states - epidemiology (52) 52
streptococcus pneumoniae - genetics (51) 51
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (739) 739
French (10) 10
Italian (6) 6
Spanish (6) 6
German (5) 5
Japanese (5) 5
Dutch (4) 4
Swedish (2) 2
Chinese (1) 1
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Long-term impact of a "3 + 0" schedule for 7- And 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002-2014
by Jayasinghe, Sanjay and Menzies, Rob and Chiu, Clayton and Toms, Cindy and Blyth, Christopher C and Krause, Vicki and Mcintyre, Peter
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 64, Issue 2, pp. 175 - 183
Vaccine impact | PCV7 | Invasive pneumococcal disease | PCV13 | Australia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Heptavalent Pneumococcal Conjugate Vaccine - immunology | Streptococcus pneumoniae - classification | History, 21st Century | Outcome Assessment (Health Care) | Humans | Middle Aged | Vaccination | Child, Preschool | Infant | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Streptococcus pneumoniae - immunology | Young Adult | Vaccines, Conjugate - immunology | Aged, 80 and over | Adult | Female | Immunization Schedule | Child | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | Serogroup | Australia - epidemiology | Vaccines, Conjugate - administration & dosage | Pneumococcal Infections - epidemiology | Pneumococcal Infections - history | Adolescent | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Aged | Population Surveillance | Usage | Care and treatment | Diagnosis | Pneumococcal vaccine | Pneumococcal infections | Schedules | Immunization | Bacterial infections | Vaccines | Drug dosages | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012
by Lepoutre, A and Varon, E and Georges, S and Dorléans, F and Janoir, C and Gutmann, L and Lévy-Bruhl, D and the Microbiologists of the Epibac and the ORP Networks and Microbiologists Epibac and ORP Networks and Microbiologists of Epibac
Vaccine, ISSN 0264-410X, 2014, Volume 33, Issue 2, pp. 359 - 366
Allergy and Immunology | Vaccine impact | Serotype replacement | Invasive pneumococcal disease | Population surveillance | Pneumococcal conjugate vaccines | France | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | France - epidemiology | Humans | Middle Aged | Vaccination | Serogroup | Child, Preschool | Infant | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Vaccines, Conjugate - administration & dosage | Young Adult | Time Factors | Adolescent | Pneumococcal Infections - prevention & control | Adult | Female | Aged | Child | Population Surveillance | Infant, Newborn | Serotyping | Vaccines | Meningitis | Immunization | Pneumonia | Hospitals | Laboratories | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: A randomized controlled trial
by Van Gils, Elske J. M and Veenhoven, Reinier H and Hak, Eelko and Rodenburg, Gerwin D and Bogaert, Debby and IJzerman, Ed P. F and Bruin, Jacob P and Van Alphen, Loek and Sanders, Elisabeth A. M
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2009, Volume 302, Issue 2, pp. 159 - 167
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Streptococcus pneumoniae - classification | Humans | Child, Preschool | Heptavalent Pneumococcal Conjugate Vaccine | Infant | Pneumococcal Vaccines - administration & dosage | Streptococcus pneumoniae - isolation & purification | Carrier State - prevention & control | Pneumococcal Infections - prevention & control | Immunization Schedule | Vaccines, Conjugate | Nasopharynx - microbiology | Infant, Newborn | Serotyping | Babies | Clinical trials | Effects | Vaccines | Streptococcus infections
Journal Article
Details down arrow
4. Full Text Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona before and after Pediatric 7-Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007
by Carmen Ardanuy and Fe Tubau and Román Pallares and Laura Calatayud and María Angeles Domínguez and Dora Rolo and Inmaculada Grau and Rogelio Martín and Josefina Liñares
Clinical infectious diseases, ISSN 1058-4838, 1/2009, Volume 48, Issue 1, pp. 57 - 64
Conjugate vaccines | Infectious diseases | Vaccination | Articles and Commentaries | Adults | Population dynamics | Children | Epidemiology | Emerging diseases | Genotypes | Streptococcus pneumoniae | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Heptavalent Pneumococcal Conjugate Vaccine | Incidence | Pneumococcal Infections - epidemiology | Pneumococcal Infections - immunology | Spain - epidemiology | Adolescent | Aged, 80 and over | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Adult | Pneumococcal Infections - microbiology | Aged | Child | Herd immunity | Demographic aspects | Distribution | Dosage and administration | Research | Pneumococcal vaccine | Pneumococcal infections | Pediatrics | Respiratory diseases | Bacteria | Vaccines | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000 June 30, 2016
by Oligbu, Godwin and Collins, Sarah and Djennad, Abdelmajid and Sheppard, Carmen L and Fry, Norman K and Andrews, Nick J and Borrow, Ray and Ramsay, Mary E and Ladhani, Shamez N
Emerging infectious diseases, ISSN 1080-6040, 09/2019, Volume 25, Issue 9, pp. 1708 - 1718
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | Mass Vaccination | Wales - epidemiology | Humans | Middle Aged | Child, Preschool | Meningitis, Pneumococcal - prevention & control | Infant | Male | Meningitis, Pneumococcal - mortality | Pneumococcal Vaccines - administration & dosage | Incidence | Streptococcus pneumoniae - immunology | Young Adult | England - epidemiology | Adolescent | Adult | Female | Meningitis, Pneumococcal - epidemiology | Vaccines, Conjugate | Aged | Child | Infant, Newborn | Bacterial meningitis | Vaccines | Index Medicus | PCV13 | Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016 | bacteria | conjugate vaccines | Wales | meningitis | serotype 8 | England | invasive pneumococcal disease | Research | case-fatality rate | Streptococcus pneumoniae | epidemiology | PCV7 | pneumococcal meningitis | immunization | case fatality rate | incidence | serotype
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
by Whitney, Cynthia G and Goldblatt, David and O’Brien, Katherine L
The Pediatric infectious disease journal, ISSN 0891-3668, 01/2014, Volume 33 Suppl 2, Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants : A Landscape Analysis of Evidence Supportin g Different Schedules, Issue Supplement 2, pp. S172 - S181
Pediatrics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Vaccines, Conjugate - administration & dosage | United States | Humans | Child, Preschool | Pneumococcal Infections - prevention & control | Heptavalent Pneumococcal Conjugate Vaccine | Immunization Schedule | Infant | Pneumococcal Vaccines - administration & dosage | Health Policy | Infant, Newborn | Index Medicus | Supplement | disease prevention | children | pneumococcal vaccine | policy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members
by Eugene V. Millar and James P. Watt and Melinda A. Bronsdon and Jean Dallas and Raymond Reid and Mathuram Santosham and Katherine L. O'Brien
Clinical infectious diseases, ISSN 1058-4838, 10/2008, Volume 47, Issue 8, pp. 989 - 996
Conjugate vaccines | Communities | Vaccination | Articles and Commentaries | Experimentation | Adults | Infants | Children | Epidemiology | Streptococcus pneumoniae | Age groups | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Carrier State - epidemiology | United States - epidemiology | Streptococcus pneumoniae - classification | Prevalence | Humans | Middle Aged | Carrier State - microbiology | Child, Preschool | Family Health | Infant | Male | Streptococcus pneumoniae - immunology | Streptococcus pneumoniae - isolation & purification | Aged, 80 and over | Adult | Female | Pneumococcal Infections - microbiology | Nasopharynx - microbiology | Child | Serotyping | Heptavalent Pneumococcal Conjugate Vaccine | Clinical Trials as Topic | Pneumococcal Infections - epidemiology | Family Characteristics | Carrier State - prevention & control | Adolescent | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Aged | Meningococcal Vaccines - immunology | Dosage and administration | Carrier state (Communicable diseases) | Research | Demographic aspects | Pneumococcal vaccine | Clinical trials | Infectious diseases | Disease transmission | Vaccines | Effects | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands
by Wagenvoort, Gertjan H.J and Sanders, Elisabeth A.M and Vlaminckx, Bart J and Elberse, Karin E and de Melker, Hester E and van der Ende, Arie and Knol, Mirjam J
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 8, pp. 1077 - 1085
Allergy and Immunology | Pneumococcal conjugate vaccine | Invasive pneumococcal disease | Sentinel surveillance | Epidemiology | Clinical outcomes | Streptococcus pneumoniae | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | Empyema - microbiology | Streptococcus pneumoniae - classification | Humans | Middle Aged | Netherlands - epidemiology | Serogroup | Child, Preschool | Pneumococcal Infections - mortality | Infant | Incidence | Young Adult | Pneumococcal Infections - epidemiology | Adolescent | Aged, 80 and over | Empyema - epidemiology | Pneumococcal Infections - prevention & control | Adult | Aged | Child | Infant, Newborn | Sentinel Surveillance | Cross infection | Infants | Nosocomial infections | Vaccines | Patient outcomes | Pneumonia | Bacterial pneumonia | Meningitis | Laboratories | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
by Ojal, John and Hammitt, Laura L and Gaitho, John and Scott, J. Anthony G and Goldblatt, David
Vaccine, ISSN 0264-410X, 08/2017, Volume 35, Issue 35, pp. 4652 - 4657
Pneumococcal conjugate vaccine | Hyporesponsiveness | Nasopharyngeal carriage | Correlates of protection | Kenya | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Heptavalent Pneumococcal Conjugate Vaccine - immunology | Carrier State - epidemiology | Immunoglobulin G - blood | Kenya - epidemiology | Humans | Vaccines, Conjugate - adverse effects | Carrier State - microbiology | Infant | Male | Pneumococcal Vaccines - administration & dosage | Vaccination - adverse effects | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Pneumococcal Infections - immunology | Female | Pneumococcal Vaccines - adverse effects | Nasopharynx - microbiology | Antibodies, Bacterial - blood | Infant, Newborn | Serotyping | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | Carrier State - immunology | Serogroup | Vaccines, Conjugate - administration & dosage | Pneumococcal Infections - epidemiology | Heptavalent Pneumococcal Conjugate Vaccine - adverse effects | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Infants | Vaccines | Immunoglobulin G | Vaccination | Medical research | Analysis | Medicine, Experimental | Police | Neonates | Immune response | Thresholds | Clinical trials | Data processing | Homology | Disease control | Streptococcus infections | Carriers | Immunogenicity | Newborn babies | Serotypes | Population control | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
by Ron Dagan and Scott Patterson and Christine Juergens and David Greenberg and Noga Givon-Lavi and Nurith Porat and Alejandra Gurtman and William C. Gruber and Daniel A. Scott
Clinical infectious diseases, ISSN 1058-4838, 10/2013, Volume 57, Issue 7, pp. 952 - 962
Pediatrics | Conjugate vaccines | Immune response | Infectious diseases | Vaccination | Clinical trials | Infants | Toddlers | Children | ARTICLES AND COMMENTARIES | Age | Serotype prevalence | Pneumococcal conjugate vaccine | S. pneumoniae | Immunogenicity | Nasopharyngeal colonization | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Carrier State - immunology | Streptococcus pneumoniae - classification | Double-Blind Method | Humans | Carrier State - microbiology | Child, Preschool | Heptavalent Pneumococcal Conjugate Vaccine | Infant | Male | Pneumococcal Vaccines - administration & dosage | Streptococcus pneumoniae - immunology | Pneumococcal Infections - immunology | Streptococcus pneumoniae - isolation & purification | Carrier State - prevention & control | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Female | Pneumococcal Infections - microbiology | Nasopharynx - microbiology | Antibodies, Bacterial - blood | Prevention | Dosage and administration | Research | Pneumococcal vaccine | Comparative analysis | Pneumonia, Pneumococcal | Immunoglobulins | Vaccines | Effectiveness studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights